DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,492,489 | +3.7% | 1,594,085 | +0.3% | 0.34% | +4.0% |
| Q2 2023 | $381,347,520 | -31.7% | 1,588,948 | -28.3% | 0.33% | -33.9% |
| Q1 2023 | $558,407,726 | -15.7% | 2,215,552 | -11.2% | 0.50% | -12.4% |
| Q4 2022 | $662,450,365 | -0.7% | 2,495,857 | -3.4% | 0.56% | -8.0% |
| Q3 2022 | $667,082,000 | +7.2% | 2,582,686 | +5.2% | 0.61% | +5.5% |
| Q2 2022 | $622,259,000 | -14.6% | 2,454,477 | -1.2% | 0.58% | +2.8% |
| Q1 2022 | $728,410,000 | -14.0% | 2,483,243 | -3.5% | 0.57% | -0.2% |
| Q4 2021 | $847,010,000 | +6.2% | 2,574,419 | -1.8% | 0.57% | -4.9% |
| Q3 2021 | $797,914,000 | +13.9% | 2,620,923 | +0.4% | 0.60% | +13.5% |
| Q2 2021 | $700,416,000 | +19.2% | 2,609,987 | -0.1% | 0.52% | +17.4% |
| Q1 2021 | $587,810,000 | -0.8% | 2,611,559 | -2.1% | 0.45% | -2.2% |
| Q4 2020 | $592,487,000 | +5.7% | 2,667,179 | +2.4% | 0.46% | -8.4% |
| Q3 2020 | $560,595,000 | +24.9% | 2,603,422 | +2.6% | 0.50% | +12.6% |
| Q2 2020 | $448,858,000 | +32.8% | 2,538,360 | +3.9% | 0.44% | +8.3% |
| Q1 2020 | $338,036,000 | -13.2% | 2,442,279 | -3.8% | 0.41% | +15.9% |
| Q4 2019 | $389,574,000 | +4.7% | 2,538,273 | -1.5% | 0.35% | -4.6% |
| Q3 2019 | $372,020,000 | +17.8% | 2,575,783 | +16.6% | 0.37% | -0.8% |
| Q2 2019 | $315,855,000 | +12.7% | 2,210,011 | +4.2% | 0.37% | +8.1% |
| Q1 2019 | $280,140,000 | +34.0% | 2,121,949 | +4.6% | 0.34% | +17.7% |
| Q4 2018 | $209,131,000 | +13.0% | 2,028,038 | +19.0% | 0.29% | +22.6% |
| Q3 2018 | $185,127,000 | -0.8% | 1,703,730 | -10.0% | 0.24% | -7.4% |
| Q2 2018 | $186,709,000 | +34.0% | 1,892,069 | +32.9% | 0.26% | +30.3% |
| Q1 2018 | $139,385,000 | +6.7% | 1,423,602 | +1.2% | 0.20% | +11.9% |
| Q4 2017 | $130,628,000 | +14.3% | 1,407,329 | +5.6% | 0.18% | +4.1% |
| Q3 2017 | $114,266,000 | +7.4% | 1,332,078 | +5.6% | 0.17% | 0.0% |
| Q2 2017 | $106,416,000 | +1.9% | 1,260,999 | +3.3% | 0.17% | 0.0% |
| Q1 2017 | $104,432,000 | -1.4% | 1,220,999 | -10.3% | 0.17% | -4.5% |
| Q4 2016 | $105,917,000 | +8.7% | 1,360,699 | +9.5% | 0.18% | +11.2% |
| Q3 2016 | $97,454,000 | -26.8% | 1,243,199 | -5.7% | 0.16% | -25.9% |
| Q2 2016 | $133,179,000 | +4.0% | 1,318,599 | -2.3% | 0.22% | +4.9% |
| Q1 2016 | $128,013,000 | -1.5% | 1,349,499 | -3.5% | 0.21% | +0.5% |
| Q4 2015 | $129,952,000 | +51.8% | 1,399,140 | +39.2% | 0.20% | +41.4% |
| Q3 2015 | $85,622,000 | -37.4% | 1,004,840 | -37.1% | 0.14% | -29.3% |
| Q2 2015 | $136,769,000 | -5.3% | 1,597,954 | -6.4% | 0.20% | +2.5% |
| Q1 2015 | $144,477,000 | 0.0% | 1,706,954 | 0.0% | 0.20% | 0.0% |
| Q4 2014 | $144,477,000 | +2.3% | 1,706,954 | -8.2% | 0.20% | +2.6% |
| Q3 2014 | $141,211,000 | +2.2% | 1,858,522 | +5.9% | 0.20% | +3.7% |
| Q2 2014 | $138,176,000 | -1.5% | 1,755,064 | -7.4% | 0.19% | -6.5% |
| Q1 2014 | $140,343,000 | -1.2% | 1,895,766 | +2.7% | 0.20% | -1.5% |
| Q4 2013 | $141,976,000 | +33.3% | 1,845,764 | +20.2% | 0.20% | +3.6% |
| Q3 2013 | $106,479,000 | +11.0% | 1,536,048 | +1.4% | 0.20% | +2.6% |
| Q2 2013 | $95,935,000 | – | 1,515,559 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |